Biotech · Private company
Harmony Biosciences Management, Inc.
Track this companyFree. Adds Harmony Biosciences Management, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials209 recruiting or active
Pipeline programs17From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline17
- Double-blind PitolisantPhase 3 · Idiopathic HypersomniaClinicalTrials.gov · fetched Nov 12, 2026
- HBS-301Phase 3 · EDSClinicalTrials.gov · fetched Nov 12, 2026
- HBS-301 tabletPhase 3 · Idiopathic HypersomniaClinicalTrials.gov · fetched Nov 12, 2026
- Open-label PitolisantPhase 3 · Idiopathic HypersomniaClinicalTrials.gov · fetched Nov 12, 2026
- PitolisantPhase 3 · Idiopathic HypersomniaClinicalTrials.gov · fetched Nov 12, 2026
- PitolisantPhase 3 · Prader-Willi SyndromeClinicalTrials.gov · fetched Nov 12, 2026
- Pitolisant tabletPhase 3 · Prader-Willi SyndromeClinicalTrials.gov · fetched Nov 12, 2026
- ZYN002Phase 3 · Fragile X SyndromeClinicalTrials.gov · fetched Nov 12, 2026
- Pitolisant Oral TabletPhase 2 · Myotonic Dystrophy 1ClinicalTrials.gov · fetched Nov 12, 2026
- Pitolisant oral tabletsPhase 2 · Prader-Willi SyndromeClinicalTrials.gov · fetched Nov 12, 2026
- ZYN002Phase 2 · 22Q11.2 Deletion SyndromeClinicalTrials.gov · fetched Nov 12, 2026
- HBS-104Phase 1 · Sleep DeprivationClinicalTrials.gov · fetched Nov 12, 2026
- HBS-201Phase 1 · NarcolepsyClinicalTrials.gov · fetched Nov 12, 2026
- Pitolisant delayed-releasePhase 1 · Healthy ParticipantsClinicalTrials.gov · fetched Nov 12, 2026
- Comparator ProductsPregnancy RelatedClinicalTrials.gov · fetched Nov 12, 2026
- PitolisantNarcolepsy Without CataplexyClinicalTrials.gov · fetched Nov 12, 2026
- PitolisantPregnancy RelatedClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials20
- Study of Single Doses of HBS-104 in Acutely Sleep-deprived Healthy ParticipantsPHASE1 · RECRUITING · started Aug 28, 2026ClinicalTrials.gov NCT07848659 · fetched Nov 12, 2026
- A Single and Multiple Ascending Dose Study of EPX-100 in Healthy Adult ParticipantsPHASE1 · RECRUITING · started Aug 5, 2026ClinicalTrials.gov NCT07879170 · fetched Nov 12, 2026
- A Food Effect Study of Pitolisant Delayed-Release in Healthy Adult ParticipantsPHASE1 · COMPLETED · started Jun 18, 2026ClinicalTrials.gov NCT07860736 · fetched Nov 12, 2026
- A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With NarcolepsyPHASE3 · RECRUITING · started Jun 4, 2026ClinicalTrials.gov NCT07675135 · fetched Nov 12, 2026
- A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Idiopathic Hypersomnia (IH)PHASE3 · RECRUITING · started Mar 16, 2026ClinicalTrials.gov NCT07500090 · fetched Nov 12, 2026
- A Study of Pitolisant in Participants With Prader-Willi SyndromePHASE3 · ENROLLING_BY_INVITATION · started Aug 20, 2025ClinicalTrials.gov NCT07219485 · fetched Nov 12, 2026
- A Study of HBS-201 (Pitolisant Delayed-release)PHASE1 · COMPLETED · started May 21, 2025ClinicalTrials.gov NCT07051252 · fetched Nov 12, 2026
- An Efficacy and Safety Study of Clemizole HCl in Patients With Lennox-Gastaut SyndromePHASE3 · RECRUITING · started Apr 9, 2025ClinicalTrials.gov NCT05066217 · fetched Nov 12, 2026
- Drug-drug Interaction Study of Clemizole (EPX-100) in Healthy ParticipantsPHASE1 · COMPLETED · started Jan 15, 2025ClinicalTrials.gov NCT07824193 · fetched Nov 12, 2026
- A Study of Pitolisant in Patients With Prader-Willi SyndromePHASE3 · RECRUITING · started May 28, 2024ClinicalTrials.gov NCT06366464 · fetched Nov 12, 2026
- Pitolisant in Refractory Restless Legs SyndromePHASE4 · UNKNOWN · started Sep 20, 2022ClinicalTrials.gov NCT05581576 · fetched Nov 12, 2026
- A Long-Term Safety and Effectiveness Study to Evaluate Pitolisant in Adult Patients With Idiopathic HypersomniaPHASE3 · COMPLETED · started Aug 19, 2022ClinicalTrials.gov NCT05458128 · fetched Nov 12, 2026
- A Phase 3 Study to Assess the Safety and Efficacy of Pitolisant in Adult Patients With Idiopathic HypersomniaPHASE3 · COMPLETED · started May 25, 2022ClinicalTrials.gov NCT05156047 · fetched Nov 12, 2026
- Clinical Study of Cannabidiol in Children, Adolescents, and Young Adults With Fragile X SyndromePHASE3 · COMPLETED · started Sep 13, 2021ClinicalTrials.gov NCT04977986 · fetched Nov 12, 2026
- WAKIX® (Pitolisant) Pregnancy RegistryRECRUITING · started Aug 24, 2021ClinicalTrials.gov NCT05536011 · fetched Nov 12, 2026
- Safety and Efficacy of Pitolisant on Excessive Daytime Sleepiness and Other Non-Muscular Symptoms in Patients With Myotonic Dystrophy Type 1PHASE2 · COMPLETED · started Jun 28, 2021ClinicalTrials.gov NCT04886518 · fetched Nov 12, 2026
- A Phase 2 Study to Evaluate the Safety and Efficacy of Pitolisant in Patients With Prader-Willi Syndrome, Followed by an Open Label ExtensionPHASE2 · COMPLETED · started Dec 9, 2020ClinicalTrials.gov NCT04257929 · fetched Nov 12, 2026
- A Study of EPX-100 (Clemizole Hydrochloride) in Participants With Dravet SyndromePHASE3 · RECRUITING · started Sep 15, 2020ClinicalTrials.gov NCT04462770 · fetched Nov 12, 2026
- Open-Label Study of ZYN002 Administered as a Transdermal Gel to Children and Adolescents With 22q11.2 Deletion Syndrome (INSPIRE)PHASE2 · COMPLETED · started Feb 19, 2020ClinicalTrials.gov NCT05149898 · fetched Nov 12, 2026
- Expanded Access Program to Provide Treatment With Pitolisant to Adult Patients in the U.S. With Excessive Daytime Sleepiness Associated With Narcolepsy With or Without CataplexyNO_LONGER_AVAILABLEClinicalTrials.gov NCT03433131 · fetched Nov 12, 2026